# Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment

> **NCT04469907** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 18 (actual)

## Conditions studied

- Renal Impairment

## Interventions

- **DRUG:** AZD9977

## Key facts

- **NCT ID:** NCT04469907
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-22
- **Primary completion:** 2021-10-28
- **Final completion:** 2021-10-28
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04469907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04469907, "Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04469907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*